Endocrinology

During a press conference at Kidney Week 2011, Sandra Amaral, MD, MHS, Children's Hospital of Philadelphia, stressed how important it is for pediatricians and pediatric nephrologists to promote the process of kidney transplant to happen as soon as possible in children who are diagnosed with ESRD.

In an effort to hurry along the FDA approval process for the artificial pancreas, members of the Juvenile Diabetes Research Foundation, government officials, health care professionals, and a large number of type 1 diabetics congregated in Washington, DC.

According to a report in the August 2009 issue of Diabetes Care, even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial.

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

On Monday, President Obama signed an executive order directing the United States Food and Drug Administration (FDA) to take measures which will reduce drug shortages.

Watson Pharmaceuticals, Inc., has announced that the FDA approved its Androderm testosterone transdermal system at reduced doses of 2 mg/day and 4 mg/day.

A new study by Japanese researchers may support transplanting neural stems cells into a patient's pancreas as a viable treatment for type 1 diabetes.

The US Food and Drug Administration (FDA) has approved exenatide (Byetta), the type 2 diabetes drug, as an additional therapy for diabetic adults who are already dieting, exercising, and taking insulin glargine.

Tobacco disease is considered by many to be a non-communicable disease epidemic with approximately six million needless deaths due to tobacco use worldwide each year.

Scientists at Stanford University have identified a pathway responsible for age-related beta cell decline.

Patients with type 1 diabetes who experience hyperglycemia or severe hypoglycemia in their youth are at risk of impaired brain development, a new study finds.

Patients are starting dialysis approximately an average of five months earlier, but with no discernable evidence of benefits.

The FDA today approved Juvisync, the first combination drug developed to treat type 2 diabetes and high cholesterol.

The largest ever genome-wide association study of those with type 1 diabetes has discovered three new genetic anomalies associated with the disease.

People with chronic kidney disease, even those who have undergone a kidney transplant, can benefit from regular physical exercise.

New research has found evidence confirming that patients with diabetes have a higher risk of developing colon cancer.

Men are more prone to developing type 2 diabetes at a lower BMI than women.

A recent study has found that it can be very difficult for children who suffer from both type 1 diabetes and asthma to regulate their blood sugar.

Individuals with diabetes have a significantly higher risk of developing Alzheimer's disease and other forms of dementia, a new study finds.

Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.

Intranasal insulin improves memory, thinking, and functioning in people with mild cognitive impairment and Alzheimer's disease, a small pilot trial indicates.

A project to be launched in Texas will test the ability of mobile health devices to help patients control diabetes.

Researchers have created prototype drugs that have powerful anti-diabetic effects, yet are apparently free of dangerous side effects.

The FDA has approved an update of the drug label of Reclast due to new evidence showing that it may increase the risk of kidney failure.

Mobile health applications show great promise for the management of chronic illnesses like diabetes.

Measuring a patient's waist circumference is not a better method of identifying an increased risk of developing type 2 diabetes than measuring BMI.

Officials from congress have requested that the government investigate the potential risks posed by wireless medical devices.

Diabetics rejoice! Thanks to a new add-on device for smartphones, the days of finger-pricking for glucose readings may soon be over.

The latest clinical research on the detection and treatment of gout.

According to a York University study, a recently-identified protein may help keep appetite and blood sugar down.